Comparisons between phencyclidine, its monohydroxylated metabolites, and the stereoisomers of N-allyl-N-normetazocine (SKF 10047) as inhibitors of the muscarinic receptor and acetylcholinesterase.
D000110:Acetylcholinesterase; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002800:Cholinesterase Inhibitors; D066298:In Vitro Techniques; D008297:Male; D008566:Membranes / Q000378:metabolism; D010276:Parasympatholytics; D010620:Phenazocine / Q000031:analogs & derivatives* / Q000494:pharmacology; D010622:Phencyclidine / Q000031:analogs & derivatives / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism
D002800:Cholinesterase Inhibitors; D010276:Parasympatholytics; D011813:Quinuclidinyl Benzilate; C012134:SK&F 10047; D000110:Acetylcholinesterase; D010620:Phenazocine; D010622:Phencyclidine